Visalytics
Visalytics
approved EB-2 (NIW)

Post-Doctoral Fellow

Translational Immunology · India · 2025-04-08

Processing Time
311 days
Decision Date
2025-04-08
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in translational immunology, specifically focusing on identifying biomarkers and refining immunotherapeutic strategies for peanut and copper allergies. His work involves advancing allergy diagnostics and understanding the underlying mechanisms of lethal allergic reactions to improve patient outcomes. The intended impact is to enhance preventative healthcare practices and develop effective treatments for rising health concerns in the U.S. biomedical community.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses lethal allergic conditions which are a rising health concern nationwide, directly contributing to preventative healthcare.

2 Well-positioned to Advance the Endeavor Met

The petitioner has an extensive publication record, high citation count, and has secured funding from major federal agencies like the NIH and DOE.

3 Balance of Factors to Waive Job Offer Met

The petitioner's unique expertise in identifying biomarkers for allergies makes his continued work highly beneficial to U.S. national and global health interests.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 10 peer-reviewed journal articles (5 as first or co-first author) and 889 citations from researchers in 63 countries. He demonstrated leadership through over 50 peer reviews and service as a guest editor for respected journals. The case was further supported by research funding from prestigious institutions like the NIH, NIAID, and the U.S. Department of Energy, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Business Manager

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
323 days 2025-06-16
The petitioner proposes to continue her research in the pharmaceutical industry focusing on precision medicine for autoimmune and inflammatory diseases. She utilizes multi-color flow cytometry and genetic variation analysis to identify immune pathways for the development of novel, personalized therapeutics for rare and severe immune-related conditions.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Pennsylvania 64 days 2025-11-26
The petitioner proposes to continue research on the fundamental mechanisms of cellular stress response and immune system function to advance vaccine development and biotherapeutics. The work utilizes antibody engineering and advanced sequencing technologies to create practical innovations for protecting vulnerable populations from respiratory infections. The intended impact is to address nationwide public health challenges and improve national health security through immediate therapeutic potential.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Others

Biotechnology · Egypt

WeGreened EB-2 (NIW) approved
Pennsylvania 6 days 2024-01-16
The petitioner proposes to examine signaling pathways in platelets and immune cells to support the development of targeted therapies for autoimmune diseases, allergies, and infectious diseases. Her work focuses on leveraging host defense mechanisms to combat antimicrobial resistance and mitigate the economic impact of immune-related conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 311 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist